Company Overview and News
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
A CONTRACT to operate and maintain (O&M) for 25 years an expanded Clark International Airport — designed to decongest the premier gateway in Metro Manila — has attracted several groups that sent representatives to a pre-bid conference in Bonifacio Global City, Taguig City on Monday.
Sony Corp. President Kenichiro Yoshida speaks as characters from Peanuts are shown at a press conference at the company’s headquarters Tuesday, May 22, 2018, in Tokyo. (AP)
The employees stake in the company may soon be worth US$1 billion to US$3 billion, depending on the stock sale. That works out to $36 million each at the midpoint
Among the so-called recovery stories, Sony Corp (ADR) (NYSE:SNE) is one of the more intriguing, and frustrating. Last year, SNE stock turned in a massive performance, delivering 60% returns to long-embattled shareholders. This followed a fairly solid 15% haul in 2016.
HONG KONG – After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture capital money to fund his business idea.
Hong Kong: After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture-capital money to fund his business idea.
Entrepreneur combined his Google money with his mom’s, and with less than US$1 million in seed capital moved from California to Shenzhen to build his technology business
Shares of Applied Materials fell sharply Friday after the company lowered its current-quarter revenue and sales projections in its semiconductor business below Wall Street expectations.
Looking for high growth and a dirt-cheap valuation? Plenty of companies fit the former or the latter, many don’t fit either and a rare few can claim both descriptions. Micron Technology, Inc. (NASDAQ:MU) is one of the latter. Despite this, however, MU stock hasn’t been as much of a no-brainer trade as some investors may think.
The anti-monopoly review had been the last and biggest hurdle to a successful sale of Toshiba Memory
Asian markets were muted in early trading Friday, as investors appeared to be readjusting their expectations about trade negotiations between the U.S. and China.
SEOUL: South Korea’s LG Corp said its long-time chairman is unwell and that it plans to nominate his son to its board of directors in preparation for leadership succession.
SEOUL, May 18 (Reuters) - South Korean drugmaker Samsung BioLogics said on Friday joint venture partner Biogen would exercise its call option to increase its stake to 50 percent minus one share in Samsung Bioepis.
TOKYO (Reuters) - Toshiba Corp (6502.T) said on Thursday that China regulators have approved the $18 billion sale of its chip unit to a consortium led by U.S. private equity firm Bain Capital, marking the end to a year-long saga surrounding its most prized asset.
23h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
23h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...